D. S. Stephens, B. Greenwood, and P. Brandtzaeg, Epidemic meningitis, meningococcaemia, and Neisseria meningitidis, Lancet, vol.369, pp.2196-210, 2007.

A. Banzhoff, Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States, Ther Adv Vaccines, vol.5, pp.3-14, 2017.

J. Findlow, Vaccines for the prevention of meningococcal capsular group B disease: what have we recently learned?, Hum Vaccin Immunother, vol.12, pp.235-243, 2016.

D. Serruto, M. J. Bottomley, S. Ram, M. M. Giuliani, and R. Rappuoli, The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens, Vaccine, vol.30, issue.2, pp.87-97, 2012.

R. Borrow, G. M. Carlone, N. Rosenstein, M. Blake, I. Feavers et al., Neisseria meningitidis group B correlates of protection and assay standardization-international meeting, Vaccine, vol.24, pp.5093-107, 2005.

J. Donnelly, D. Medini, G. Boccadifuoco, A. Biolchi, J. Ward et al., Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines, Proc Natl Acad Sci, vol.107, pp.19490-19495, 2010.

J. Findlow and R. Borrow, Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?, Pathog Dis, vol.75, p.25, 2017.

D. Medini, M. Stella, and J. Wassil, MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine, Vaccine, vol.33, pp.2629-2665, 2015.

B. D. Plikaytis, M. Stella, G. Boccadifuoco, L. M. Detora, M. Agnusdei et al., Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines, Clin Vaccine Immunol, vol.19, pp.1609-1626, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-02085510

G. Frosi, A. Biolchi, L. Sapio, M. Rigat, F. Gilchrist et al., Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage, Vaccine, vol.31, pp.4968-74, 2013.

S. Budroni, A. Kleinschmidt, P. Boucher, and D. Medini, Pooled-sera hSBA titres predict individual seroprotection in infants and toddlers vaccinated with 4CMenB, Vaccine, vol.34, pp.2579-84, 2016.

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, H. Claus et al., Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, pp.416-441, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093031

G. Tzanakaki, E. Hong, K. Kesanopoulos, A. Xirogianni, S. Bambini et al., Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine, BMC Microbiol, vol.14, p.111, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-00990250

I. Was´kowas´ko, E. Hong, D. Paola, R. Stella, M. Moschioni et al., High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland, Vaccine, vol.34, pp.510-515, 2016.

M. J. Simões, C. Bettencourt, D. Paola, R. Giuliani, M. Pizza et al., Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal, PLoS One, vol.12, p.176177, 2017.

J. A. Bettinger, D. W. Scheifele, S. A. Halperin, W. Vaudry, J. Findlow et al., Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB), Vaccine, vol.32, pp.124-154, 2013.

R. Abad, V. Medina, M. Stella, G. Boccadifuoco, M. Comanducci et al., Predicted strain coverage of a new meningococcal multicomponent vaccine (4CMenB) in Spain: Analysis of the differences with other European countries, PLoS One, vol.11, p.150721, 2016.

S. R. Parikh, L. Newbold, S. Slater, M. Stella, M. Moschioni et al., Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment, Lancet Infect Dis, vol.17, pp.754-62, 2017.

G. Rajam, M. Stella, E. Kim, S. Paulos, G. Boccadifuoco et al., Antigen Typing System (MATS)-based Neisseria meningitidis serogroup B coverage prediction for the MenB-4C vaccine in the United States, vol.2, pp.261-317, 2017.

M. Toropainen, A. Vainio, M. Moschioni, R. Dp, M. Stella et al., Predicted strain coverage of four-component meningococcal serogroup B vaccine (4CMenB) in Finland, Program and abstracts of the 20th international pathogenic Neisseria conference. Manchester, UK2016, p.279

S. N. Ladhani, M. Ramsay, R. Borrow, A. Riordan, J. M. Watson et al., Enter B and W: two new meningococcal vaccine programmes launched, Arch Dis Child, vol.101, pp.91-96, 2016.

S. R. Parikh, N. J. Andrews, K. Beebeejaun, H. Campbell, S. Ribeiro et al., Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study, Lancet, vol.388, pp.2775-82, 2016.

S. A. Clark, J. Lucidarme, L. S. Newbold, and R. Borrow, Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens, PLoS One, vol.9, p.89921, 2014.

C. Azzari, F. Nieddu, M. Moriondo, G. Indolfi, C. Canessa et al., Underestimation of invasive meningococcal disease in Italy, Emerg Infect Dis, vol.22, pp.469-75, 2016.

J. Lucidarme, M. Comanducci, J. Findlow, S. J. Gray, E. B. Kaczmarski et al., Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine, Clin Vaccine Immunol, vol.17, pp.919-948, 2010.

. R-core and . Team, R: A language and environment for statistical computing, 2013.

Y. Yu and L. Lin, Agreement: Statistical tools for measuring agreement. R package version, pp.8-9, 2012.

L. Fagnocchi, A. Biolchi, F. Ferlicca, G. Boccadifuoco, B. Brunelli et al., Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine, Infect Immun, vol.81, pp.560-569, 2013.

C. Brehony, C. Rodrigues, R. Borrow, A. Smith, R. Cunney et al., Distribution of Bexsero Ò Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation, Vaccine, vol.34, pp.4690-4697, 2016.

S. Mowlaboccus, T. T. Perkins, H. Smith, T. Sloots, S. Tozer et al., Temporal changes in BEXSERO Ò antigen sequence type associated with genetic lineages of Neisseria meningitidis over a 15-year period in Western Australia, PLoS One, vol.11, p.158315, 2016.

S. A. Clark, R. Doyle, J. Lucidarme, R. Borrow, and J. Breuer, Targeted DNA enrichment and whole genome sequencing of Neisseria meningitidis directly from clinical specimens, Int J Med Microbiol, vol.308, pp.256-62, 2018.

U. Vogel, P. Stefanelli, J. Vazquez, M. K. Taha, H. Claus et al., The use of vaccine antigen characterization, for example by MATS, to guide the introduction of meningococcus B vaccines, Vaccine, vol.30, issue.2, pp.73-80, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-02085503

M. Giuliani, E. Bartolini, B. Galli, L. Santini, L. Surdo et al., Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes, Sci Rep, vol.8, p.3700, 2018.

E. Partridge, E. Lujan, S. Giuntini, D. M. Vu, and D. M. Granoff, The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C, Vaccine, vol.35, pp.4236-4280, 2017.

X. Bai and R. Borrow, Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine, Expert Rev Vaccines, vol.9, pp.1203-1220, 2010.

C. Rodrigues, H. Chan, C. Vipond, and M. Maiden, Development of Bexsero Ò outer membrane vesicle typing system for analysis of meningococcal whole genome sequences, p.17, 2017.

M. Biagini, M. Spinsanti, D. Angelis, G. Tomei, S. Ferlenghi et al., Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined, Proc Natl Acad Sci U S A, vol.113, pp.2714-2723, 2016.

C. Cayrou, A. A. Akinduko, E. M. Mirkes, J. Lucidarme, S. A. Clark et al., Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines, PLoS One, vol.13, p.197186, 2018.

M. D. Snape, D. Medini, S. A. Halperin, L. Detora, J. Drori et al., The challenge of post-implementation surveillance for novel meningococcal vaccines, Vaccine, vol.30, issue.2, pp.67-72, 2012.

K. A. Jolley and M. C. Maiden, BIGSdb: Scalable analysis of bacterial genome variation at the population level, BMC Bioinf, vol.11, p.595, 2010.